Circulating angiogenesis-related markers as predictors of benefit from regorafenib in metastatic colorectal cancer (mCRC) patients (pts)
Titel:
Circulating angiogenesis-related markers as predictors of benefit from regorafenib in metastatic colorectal cancer (mCRC) patients (pts)
Auteur:
Antoniotti, C. Marmorino, F. Pennati, M. Zaffaroni, N. Rossini, D. Borelli, B. Zucchelli, G. Moretto, R. Pietrantonio, F. Masi, G. Vannini, F. Colombo, C. Saettini, A. Gini, S. Delliponti, L. Pfanner, E. Brunetti, I. Falcone, A. Cremolini, C.